Résultats de la recherche - 28 results

Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.

a high number of patients to instead allowing precise diagnostics of suspected patients with the intention of correct management in a low-prevalence setting. Health Topics:  Human papillomavirus (HPV) and ...

Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.

aim to provide updated global and regional pooled overall, type-specific, and age-specific prevalence estimates of genital HPV infection in men. METHODS: We conducted a systematic review and ...

HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study

DNA-negatives of the other HNC-sites were tested for the presence of type-specific HPV RNA and p16 over-expression. RESULTS: The highest HPV DNA prevalence was observed in OPC (36.4 %), and was significantly ...

Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.

collection, HPV detection, and population type was extracted. Prevalences were pooled using random-effects models for meta-analyses of binomial data. Correlations were assessed by the Spearman test. RESULTS: ...

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

tests used in cervical cancer screening. In addition, hrHPV and type-specific detection HPV types were compared between INNO-LiPA and Linear Array HPV Genotyping Test (Linear Array). The prevalence of ...

Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.

blinded to the clinical data. HPV prevalence was analysed and clinical performance for detection of cervical intraepithelial neoplasia grade 3 or worse (CIN3 +) and CIN2 or worse (CIN2 +) was assessed ...

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.

Human papillomaviruses (HPV s) are the necessary cause of most cervical cancers, a large proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The knowledge about HPV has led to ...

Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.

compare conventional and liquid-based cytology (LBC), estimate the prevalence of abnormal cervical cytology and high risk HPV (hrHPV) infection and their correlation, among screened women in Luxembourg. ...

Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.

Prevalence of hrHPV types (high-risk HPV) increased with severity of cytology. The concordance between PapilloCheck and the GP5 +/6+ LMNX Assay was excellent when assessed at the qualitative hrHPV ...

Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).

a 38% (24% to 57%) higher HPV detection rate in vaginal self-samples from women over 50 years compared with those ≤29 years. Relative sensitivity and specificity of hrHPV positivity for the detection of ...

QR code

QR code for this page URL